The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the 10 best NASDAQ growth stocks to buy for the next 10 years. Andrea Tan, an ...

・Insight Molecular Diagnostics (IMDX) is a precision diagnostics company with disruptive transplant technology and strong recent price momentum. ・IMDX has surged 158% over the past year and is trading ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, amid insider sales, slow revenue growth, and weak adoption of its core ...

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Black Diamond Therapeutics, Inc. is one of ...

The average one-year price target for Krystal Biotech (NasdaqGS:KRYS) has been revised to $269.93 / share. This is an increase of 18.96% from the prior estimate of $226.90 dated December 18, 2025. The ...

Investors seeking a biotech stock with significant upside potential to add to their portfolio may want to consider Arcutis Biotherapeutics (NASDAQ: ARQT). The stock price is already up 112% in 2025, ...

With an oversubscribed trading debut now in the books, Veradermics—developing an oral version of the molecule behind ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price to jump 75% in premarket trading. The biotech, which went public late last year, ...

Unprofitable biotech Veradermics, which still needs FDA approval for its hair loss pill, surged on its debut day.